Kezar Life Sciences Is A Clinical Stage Biotechnology Company Based In South San Franciscocaliforniathe Company Specializes In Developing First In Class Small Molecule Therapies That Target Key Intracellular Proteins To Inhibit Multiple Disease Driving Cellular Pathwaysthis Innovative Approach Aims To Improve Treatments For Chronic Diseasesparticularly In Autoimmunity And Cancer The Company S Mission Is To Create Unique Therapies That Enhance The Lives Of Patients Facing Challenging Chronic Conditionskezar Life Sciences Is Dedicated To Discovering Promising Targets That Have Been Previously Unidentifiedwith The Potential To Change Treatment Paradigmstheir Product Lineup Includes Kzr 616A Selective Immunoproteasome Inhibitor For Chronic Immune Mediated Diseasesand Kzr 261Which Targets Various Autoimmune Diseases And Solid Tumors Kezar Life Sciences Employs Two Main Therapeutic Strategiesselective Immunoproteasome Inhibition And Protein Secretion Inhibitionthese Approaches Focus On Modulating The Immune System And Halting The Secretion Of Specific Proteins That Contribute To Disease Progressionaiming To Provide Effective Management Of Autoimmune Diseases And Cancer
No conferences found for this company.
| Company Name | Kezar Life Sciences Inc |
| Country |
United States
|
| Address | 4000 Shoreline Ct 300 South San Francisco Ca 94080 United States |
| Telephone | Login to View |
| Login to View |
